BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27384129)

  • 1. mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance.
    Pires DE; Blundell TL; Ascher DB
    Sci Rep; 2016 Jul; 6():29575. PubMed ID: 27384129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSM-lig: a web server for assessing and comparing protein-small molecule affinities.
    Pires DE; Ascher DB
    Nucleic Acids Res; 2016 Jul; 44(W1):W557-61. PubMed ID: 27151202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mCSM: predicting the effects of mutations in proteins using graph-based signatures.
    Pires DE; Ascher DB; Blundell TL
    Bioinformatics; 2014 Feb; 30(3):335-42. PubMed ID: 24281696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of impacts of mutations on protein structure and interactions: SDM, a statistical approach, and mCSM, using machine learning.
    Pandurangan AP; Blundell TL
    Protein Sci; 2020 Jan; 29(1):247-257. PubMed ID: 31693276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signatures.
    Pires DE; Ascher DB
    Nucleic Acids Res; 2016 Jul; 44(W1):W469-73. PubMed ID: 27216816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mCSM-AB2: guiding rational antibody design using graph-based signatures.
    Myung Y; Rodrigues CHM; Ascher DB; Pires DEV
    Bioinformatics; 2020 Mar; 36(5):1453-1459. PubMed ID: 31665262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mCSM-membrane: predicting the effects of mutations on transmembrane proteins.
    Pires DEV; Rodrigues CHM; Ascher DB
    Nucleic Acids Res; 2020 Jul; 48(W1):W147-W153. PubMed ID: 32469063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mCSM-NA: predicting the effects of mutations on protein-nucleic acids interactions.
    Pires DEV; Ascher DB
    Nucleic Acids Res; 2017 Jul; 45(W1):W241-W246. PubMed ID: 28383703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mCSM-PPI2: predicting the effects of mutations on protein-protein interactions.
    Rodrigues CHM; Myung Y; Pires DEV; Ascher DB
    Nucleic Acids Res; 2019 Jul; 47(W1):W338-W344. PubMed ID: 31114883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach.
    Pires DE; Ascher DB; Blundell TL
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W314-9. PubMed ID: 24829462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Computational Platform to Guide Drug Development Using Graph-Based Signature Methods.
    Pires DEV; Portelli S; Rezende PM; Veloso WNP; Xavier JS; Karmakar M; Myung Y; Linhares JPV; Rodrigues CHM; Silk M; Ascher DB
    Methods Mol Biol; 2020; 2112():91-106. PubMed ID: 32006280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum: a database of experimentally measured effects of mutations on structurally defined protein-ligand complexes.
    Pires DE; Blundell TL; Ascher DB
    Nucleic Acids Res; 2015 Jan; 43(Database issue):D387-91. PubMed ID: 25324307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.
    Pires DE; Blundell TL; Ascher DB
    J Med Chem; 2015 May; 58(9):4066-72. PubMed ID: 25860834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the performance of computational predictors for estimating protein stability changes upon missense mutations.
    Iqbal S; Li F; Akutsu T; Ascher DB; Webb GI; Song J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34058752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations.
    Rodrigues CHM; Pires DEV; Ascher DB
    Protein Sci; 2021 Jan; 30(1):60-69. PubMed ID: 32881105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Graph-Based Signatures to Guide Rational Antibody Engineering.
    Ascher DB; Kaminskas LM; Myung Y; Pires DEV
    Methods Mol Biol; 2023; 2552():375-397. PubMed ID: 36346604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEABED: Small molEcule activity scanner weB servicE baseD.
    Fenollosa C; Otón M; Andrio P; Cortés J; Orozco M; Goñi JR
    Bioinformatics; 2015 Mar; 31(5):773-5. PubMed ID: 25348211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OSPREY Predicts Resistance Mutations Using Positive and Negative Computational Protein Design.
    Ojewole A; Lowegard A; Gainza P; Reeve SM; Georgiev I; Anderson AC; Donald BR
    Methods Mol Biol; 2017; 1529():291-306. PubMed ID: 27914058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new protein topology graph library web server.
    Schäfer T; Scheck A; Bruneß D; May P; Koch I
    Bioinformatics; 2016 Feb; 32(3):474-6. PubMed ID: 26446136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
    Tabassum T; Azeem SM; Muwonge AN; Frey KM
    Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.